Published 2020 | Version v1

Publication Metadata-only

Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy.

Creators: Massa F; Zuppa A; Pesce G; Demichelis C; Bergamaschi M; Garnero M; Briani C; Ferrari S; Schenone A; Benedetti L

Others:: Massa, F; Zuppa, A; Pesce, G; Demichelis, C; Bergamaschi, M; Garnero, M; Briani, C; Ferrari, S; Schenone, A; Benedetti, L

Additional details

Created:: February 7, 2024
Modified:: February 7, 2024